Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 63304-723

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 63304-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-bupropion-label1 (Spl Bupropion Label1)

FDA Label Image

Spl-bupropion-label2 (Spl Bupropion Label2)

Spl-bupropion-label2 (Spl Bupropion Label2)
This is a medication called bupropion HCI, which comes in extended-release tablets (XL) and is to be taken once a day. However, it is important to note that it should not be used with Zyban or any other medication containing bupropion hydrochloride. The dosage is one tablet per day, and a Medication Guide should be dispensed with each prescription. Unfortunately, the rest of the text is not readable.*
FDA Label Image

Spl-bupropion-label3 (Spl Bupropion Label3)

FDA Label Image

Spl-bupropion-structure (Spl Bupropion Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.